Skip to main content

What the FDA labels say about taking them together

Eluxadoline and ritonavir

Eluxadoline's FDA label of July 16, 2024 names ritonavir in its drug interactions section; the ritonavir label PlainMeds reads does not name eluxadoline. The eluxadoline label: “Increased exposure to eluxadoline when coadministered with cyclosporine [ see Clinical Pharmacology () ]”

Check it at the source: the eluxadoline FDA label on DailyMed (effective July 16, 2024, Allergan, Inc.); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the eluxadoline label say about ritonavir?

Eluxadoline label, drug interactions

OATP1B1 Inhibitors Clinical Impact: Increased exposure to eluxadoline when coadministered with cyclosporine [ see Clinical Pharmacology () ] … [see Adverse Reactions ()]. Examples: cyclosporine, gemfibrozil, antiretrovirals (atazanavir, lopinavir, ritonavir, saquinavir, tipranavir), rifampin, eltrombopag

Source: FDA drug label (Viberzi), NDA206940 (Abbvie), as published by Allergan, Inc., effective July 16, 2024 (SPL set 7821bd40-4c84-4984-951b-6436ae20421a), via openFDA; the full label on DailyMed

What does the ritonavir label say about eluxadoline?

Ritonavir's label (effective July 23, 2026) does not name eluxadoline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Eluxadoline generic labelers
7Ritonavir generic labelers
EluxadolineRitonavir
Labeled forIrritable bowel syndrome, DiarrheaHIV
Boxed warningNoYes
Pharmacy cost (NADAC)$28.09 per tablet 100 mg tablet$0.607 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?